TLSA logo

TLSA
Tiziana Life Sciences Ltd

3,909
Mkt Cap
$178.28M
Volume
36,414.00
52W High
$2.60
52W Low
$1.14
PE Ratio
-9.63
TLSA Fundamentals
Price
$1.43
Prev Close
$1.50
Open
$1.50
50D MA
$1.32
Beta
0.70
Avg. Volume
167,138.45
EPS (Annual)
-$0.1558
P/B
3,488.37
Rev/Employee
$0.00
$172.69
Loading...
Loading...
News
all
press releases
Wall Street Zen Downgrades Tiziana Life Sciences (NASDAQ:TLSA) to Sell
Wall Street Zen lowered Tiziana Life Sciences from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·26d ago
News Placeholder
More News
News Placeholder
Tiziana Life Sciences (NASDAQ:TLSA) Trading 6.8% Higher - Here's What Happened
Tiziana Life Sciences (NASDAQ:TLSA) Trading 6.8% Higher - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Tiziana Life Sciences Stock Jumps As Positive Preclinical Fuels Momentum
Tiziana Life Sciences shares jump on intranasal foralumab data, while technical indicators point to mixed momentum.read more...
Benzinga·1mo ago
News Placeholder
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Down 4.4% - Should You Sell?
Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 4.4% - Should You Sell...
MarketBeat·2mo ago
News Placeholder
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 0.7% - Here's What Happened
Tiziana Life Sciences (NASDAQ:TLSA) Shares Up 0.7% - Should You Buy...
MarketBeat·3mo ago
News Placeholder
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Up 3.1% - Should You Buy?
Tiziana Life Sciences (NASDAQ:TLSA) Trading 3.1% Higher - Still a Buy...
MarketBeat·4mo ago
News Placeholder
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 7.4% - Still a Buy?
Tiziana Life Sciences (NASDAQ:TLSA) Shares Up 7.4% - What's Next...
MarketBeat·4mo ago
News Placeholder
Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 4.4% - Here's Why
Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.4% - Should You Sell...
MarketBeat·5mo ago
News Placeholder
Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.5% - Here's Why
Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 4.5% - Here's What Happened...
MarketBeat·6mo ago
News Placeholder
Tiziana Life Sciences Shares Rise On Advancing Second Asset Besides Foralumab: Retail Thinks Stock Has ‘So Much Potential’
Tiziana said that TZLS-501 may offer therapeutic advantages in managing acute and chronic inflammatory conditions.
Stocktwits·8mo ago
<
1
2
...
>

Latest TLSA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.